Renee Barnett

Renee Barnett, MBA is Chief Financial Officer of Immunovant. With two decades of experience in healthcare, Ms. Barnett is a passionate and effective leader who thrives in fast-paced, growth organizations. Ms. Barnett began her career at Eli Lilly where her roles included CFO of Lilly Austria and Switzerland, global lead for Financial Planning and Analysis, and financial lead of a partnership with Amylin pharmaceuticals. Prior to joining Immunovant, she served in a variety of executive leadership functions, including Finance, Human Resources, Data & Analytics, Call Center Operations, and Technology Transformation at AbleTo, Inc., a leading technology-enabled behavioral health provider. Ms. Barnett holds an MBA from Harvard Business School, and a BA in Physics from DePauw University.